$237.75

-2.63 (-1.10%)
Live
Previous Close

$240.39

Day Range

$236.26 - $241.085

Previous Day Range

$239.17 - $246.39

Market Cap

$9.5 billion USD

Day Vol.

316554

Previous Day Vol.

427592

Currency

USD

Primary Exchange

New York Stock Exchange

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers pr...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Penumbra reported strong Q1 2025 earnings, with sales and thrombectomy revenue growth exceeding expectations. The company is well-insulated from tariff dynamics, with most of its manufacturing and raw materials sourced domestically. Analysts see further upside potential as the company executes on its growth strategy.

Related tickers: PEN.

Read Full Article

The virtual reality (VR) market is experiencing robust growth, driven by advancements in technology and broader adoption across various sectors, including gaming, education, healthcare, and enterprise. Standalone VR headsets are gaining popularity due to their convenience and mobility, while improvements in AI and haptic feedback are enhancing the user experience.

Related tickers: SONY, MSFT, U, PEN, BCNAY.

Read Full Article
Trending Tickers

Please sign in to view